SHIP-AI Website
SHIP-AI Website
News
Team
Projects
Publications
Education
Contact
Hans-Ulrich Schildhaus
Latest
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation.
Cite
×